Zealand Pharma enrolls first patient in new study with “crown jewel”

Chief Executive Officer Adam Steensberg has actually formerly explained the firm’s long-acting amylin analog, petrelintide, as the “crown gem” of Zealand Pharma’s pipe.

发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/zealand-pharma-enrolls-first-patient-in-new-study-with-crown-jewel/

(0)
上一篇 6天前
下一篇 6天前

相关推荐

发表回复

您的电子邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。